The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of tumor homologous recombination deficiency (HRD) score with immune checkpoint inhibitor benefit in metastatic clear cell renal cell carcinoma.
 
Claud Grigg
Consulting or Advisory Role - Bayer; EMD Serono; Exelixis; Exelixis; Pfizer/EMD Serono; Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - Calithera Biosciences; Pfizer
 
Wei Sha
No Relationships to Disclose
 
Rupali Bose
Honoraria - Abbvie (I); Adaptive Biotechnologies (I); ADC Therapeutics (I); AstraZeneca (I); Bristol-Myers Squibb (I); Epizyme (I); Genmab (I); Gilead Sciences (I); Janssen Oncology (I); Karyopharm Therapeutics (I); Loxo/Lilly (I); Roche/Genentech (I); Seagen (I); TG Therapeutics (I)
Consulting or Advisory Role - Abbvie (I); Adaptive Biotechnologies (I); ADC Therapeutics (I); AstraZeneca (I); Bristol-Myers Squibb (I); Epizyme (I); Genmab (I); Gilead Sciences (I); Janssen Oncology (I); Karyopharm Therapeutics (I); Loxo/Lilly (I); Roche/Genentech (I); Seagen (I); TG Therapeutics (I)
Speakers' Bureau - Abbvie (I); AstraZeneca (I); Bristol-Myers Squibb (I); Epizyme (I); Gilead Sciences (I); Janssen Oncology (I)
Research Funding - Bristol-Myers Squibb (I); Genentech (I); Gilead Sciences (I); TG Therapeutics (I)
 
Brittany Neelands
No Relationships to Disclose
 
Landon Carter Brown
Consulting or Advisory Role - Seattle Genetics/Astellas
 
Justin T. Matulay
Consulting or Advisory Role - bristol-myers squibb; Sanofi
 
Peter E. Clark
Consulting or Advisory Role - Merck
(OPTIONAL) Uncompensated Relationships - Galil Medical
 
Earle F Burgess
Stock and Other Ownership Interests - Arvinas; Becton Dickinson; Calithera Biosciences; Exelixis; Gilead Sciences; Macrogenics; Medtronic
Honoraria - Exelixis; Janssen Oncology; Merck; Novartis; Pfizer
Consulting or Advisory Role - Johnson & Johnson
Speakers' Bureau - AstraZeneca; Exelixis
Research Funding - Astellas Pharma; Pfizer